MODULATION OF APP METABOLISM BY X11ALPHA/MINT-1
X11ALPHA/MINT-1 对 APP 代谢的调节
基本信息
- 批准号:7309712
- 负责人:
- 金额:$ 12.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs diseaseamyloid proteinsbrain metabolismcell linegene expressiongenetically modified animalshuman tissueimmunocytochemistryin situ hybridizationlaboratory mouseneuritic plaquesneuropathologypostmortempresenilinprotein localizationprotein metabolismprotein protein interactionprotein transport
项目摘要
The neuronal adaptor protein X11alpha/mint-1 interacts with amyloid precursor protein (APP) to regulate its trafficking and processing in vitro. In transfected non-neuronal cells, X11alpha inhibits alpha- and gamma- but not beta- cleavage of APP. Because the phosphotyrosine binding (PTB) domain of X11alpha interacts specifically with the APP family, X11alpha appears to inhibit gamma-cleavage of APP specifically while sparing gamma-cleavage of Notch and other substrates of regulated intramembranous proteolysis. To determine the in vivo significance of these in vitro data, we will generate and characterize novel hX11alpha transgenic mice and X11alpha knockout mice and examine murine APP metabolism. Crosses of these mice to Tg2576 mice (transgenic for the Swedish mutation of hAPP, or hAPPswe) will probe the effects of XI la on hAPPswe metabolism and on the development of partial AD-like phenotypes in aging brain. A recent human genome-wide analysis revealed significant linkage of sporadic AD to single nucleotide polymorphisms (SNPs) on chromosome 9, perhaps including the X11alpha region. We will probe genetic linkage of SNPs in the X11alpha region to sporadic AD by using genomic DNA extracted from samples from AD subjects versus carefully-matched control subjects. The specific aims are to: 1) generate X11alpha knockout and hX11alpha transgenic mice and determine effects on murine APP metabolism in brain and in primary neuronal cultures, 2) cross X11alpha knockout and hX11alpha transgenic mice with Tg2576 mice to determine a) modulatory effects on hAPPswe metabolism in brain and in neuronal cultures, and b) development of AD-like phenotypes with aging, and 3) elucidate the SNPs and haplotypes within or adjacent to the X11alpha gene of AD cases and age-, gender-, and ApoE-matched controls to determine if there is a statistically significant link to sporadic AD. Specific aim 3 will study DNA samples obtained from the Pathology Core and from other ADRCs. These results will 1) inform the normal functions
of X11alpha as well as APP and its derivatives in CNS neurons, 2) lay the groundwork for viral-vector based gene therapy of AD using either X11alpha or its PTB domain in hAPP transgenic mouse models, and 3) probe a potential genetic risk factor of sporadic AD.
神经元适配蛋白X11pha/mint-1与淀粉样前体蛋白(APP)相互作用,调节其在体外的转运和加工。在转基因的非神经细胞中,X11Alpha抑制APP的α-和γ-裂解,但不抑制β-裂解。由于X11Alpha的磷酸酪氨酸结合(PTB)结构域与APP家族特异性地相互作用,X11Alpha似乎特异性地抑制APP的伽马切割,同时阻止Notch和其他调节膜内蛋白降解的底物的伽玛切割。为了确定这些体外数据的体内意义,我们将构建和鉴定新的hX11pha转基因小鼠和X11pha基因敲除小鼠,并检测小鼠APP代谢。将这些小鼠与Tg2576小鼠(转基因HAPP瑞典突变,或hAPPswe)杂交,将探索XI la对hAPPswe代谢和老化脑中部分AD样表型发展的影响。最近的一项人类全基因组分析显示,散发性AD与9号染色体上的单核苷酸多态(SNPs)存在显著关联,可能包括X11pha区域。我们将利用从AD受试者和仔细匹配的对照组受试者样本中提取的基因组DNA来探索X11pha区域的SNPs与散发性AD的遗传联系。其具体目的是:1)建立X11pha基因敲除和hX11pha转基因小鼠并确定其对小鼠脑内和原代神经元培养中APP代谢的影响;2)将X11pha基因敲除和hX11pha转基因小鼠与Tg2576小鼠杂交,以确定a)对脑内和神经元培养中hAPPswe代谢的调节作用,以及b)AD样表型的发展;以及3)阐明AD病例和年龄、性别和ApoE匹配对照的X11pha基因内或附近的SNPs和单倍型,以确定是否存在与散发性AD有统计意义的联系。特殊目标3将研究从病理核心和其他ADRC获得的DNA样本。这些结果将1)通知正常函数
2)在HAPP转基因小鼠模型中利用X11α或其PTB结构域进行AD的病毒载体基因治疗;3)探讨散发性AD的潜在遗传危险因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND SCOTT TURNER其他文献
RAYMOND SCOTT TURNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND SCOTT TURNER', 18)}}的其他基金
SAFETY AND EFFECTIVENES OF IMMUNE GLOBULIN INTRAVENOUS
静脉注射免疫球蛋白的安全性和有效性
- 批准号:
7952022 - 财政年份:2009
- 资助金额:
$ 12.88万 - 项目类别:
MODULATION OF APP METABOLISM BY X11ALPHA/MINT-1
X11ALPHA/MINT-1 对 APP 代谢的调节
- 批准号:
6933390 - 财政年份:2005
- 资助金额:
$ 12.88万 - 项目类别:
PROTEIN PROTEIN INTERACTION TO AMYLOID PRECURSOR PROTEIN PROCESSING
蛋白质与淀粉样前体蛋白加工的相互作用
- 批准号:
6315627 - 财政年份:2000
- 资助金额:
$ 12.88万 - 项目类别:
PROTEIN PROTEIN INTERACTION TO AMYLOID PRECURSOR PROTEIN PROCESSING
蛋白质与淀粉样前体蛋白加工的相互作用
- 批准号:
6216980 - 财政年份:1999
- 资助金额:
$ 12.88万 - 项目类别:
PROTEIN PROTEIN INTERACTION TO AMYLOID PRECURSOR PROTEIN PROCESSING
蛋白质与淀粉样前体蛋白加工的相互作用
- 批准号:
6203706 - 财政年份:1989
- 资助金额:
$ 12.88万 - 项目类别:
MODULATION OF AMYLOID PRECURSOR PROTEIN METABOLISM BY X11ALPHA/MINT-1
X11ALPHA/MINT-1 对淀粉样前体蛋白代谢的调节
- 批准号:
7870455 - 财政年份:
- 资助金额:
$ 12.88万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 12.88万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 12.88万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 12.88万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 12.88万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 12.88万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 12.88万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 12.88万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 12.88万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 12.88万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 12.88万 - 项目类别:














{{item.name}}会员




